Board of Directors approved the Company’s 2019 financial statement

Clarification on News Article by Economy Daily News
March 12, 2020
The board of directors have resolved not to distribute dividends for 2019
March 13, 2020
  1. Date of occurrence of the event: Mar 13, 2020
  2. Company name: OBI Pharma Inc.
  3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office
  4. Reciprocal shareholding ratios: Not applicable
  5. Cause of occurrence:
    The 2019 Individual/Consolidated Financial Statement, detailed as below:
    Individual Financial Statement:
    Operating loss:                                                  (1,321,659) thousand dollars
    Total comprehensive loss for the period:    (1,408,001) thousand dollars
    Loss Per Share (in dollars):                                      (7.76) dollars
    Consolidated Financial Statement:
    Operating loss:                                                 (1,450,861) thousand dollars
    Total comprehensive loss for the period:   (1,440,565) thousand dollars
    Loss Per Share (in dollars):                                     (7.76) dollars
  6. Countermeasures: Not applicable
  7. Any other matters that need to be specified: None